Absci Corporation - Common Stock (NQ:ABSI)

11.07 +0.32 (+2.98%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Absci Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

AI’s ‘Penicillin Moment’: How Generative Models Are Slashing Decades of Antibiotic Research into Months

February 06, 2026

In a breakthrough that many are calling the "Penicillin Moment" of the 21st century, researchers at the Massachusetts Institute of Technology, led by bioengineering pioneer James Collins, have...

Via TokenRing AI

Topics Artificial Intelligence

Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference

December 16, 2025

From Absci Corporation

Via GlobeNewswire

Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization

December 11, 2025

From Absci Corporation

Via GlobeNewswire

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research

December 10, 2025

From Absci Corporation

Via GlobeNewswire

Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia

December 04, 2025

From Absci Corporation

Via GlobeNewswire

10 AI Stocks Worth Buying Right Now ↗

December 04, 2025

Building an artificial intelligence (AI) portfolio means looking beyond the obvious megacap names.

Via The Motley Fool

Topics Artificial Intelligence

Beyond the Hype: AI’s Quiet Revolution in Niche Sectors Reshapes Industries from Medicine to Agriculture

December 01, 2025

Artificial intelligence, often spotlighted for its advancements in mainstream applications like conversational agents and autonomous vehicles, is quietly orchestrating a profound transformation across...

Via TokenRing AI

Topics Artificial Intelligence Economy Emissions

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 13, 2025

Via Benzinga

Absci (ABSI) Q3 2025 Earnings Call Transcript ↗

November 13, 2025

Absci (ABSI) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Artificial Intelligence Earnings

Ardent Health, KinderCare Learning, Ibotta And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

November 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 13, 2025

Via Benzinga

Wednesday's after hours session: top gainers and losers ↗

November 12, 2025

As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

November 12, 2025

From Absci Corporation

Via GlobeNewswire

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

October 29, 2025

From Absci Corporation

Via GlobeNewswire

Absci to Participate in Upcoming Investor Conferences

October 27, 2025

From Absci Corporation

Via GlobeNewswire

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

October 15, 2025

From Absci Corporation

Via GlobeNewswire

Absci's AI Revolution: A New Era for Drug Discovery or a Rocky Road Ahead?

October 13, 2025

Absci (NASDAQ: ABSI), a pioneer in AI-driven drug discovery, is making significant strides with its "Integrated Drug Creation™ Platform," promising to revolutionize how new medicines are brought to...

Via MarketMinute

Topics Artificial Intelligence

2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk ↗

October 13, 2025

Absci's AI drug development platform is compelling, and its pipeline is promising...but can the company overcome execution hurdles to live up to analyst hype?

Via MarketBeat

Topics Artificial Intelligence

Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday ↗

October 08, 2025

Via Benzinga

This Synopsys Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday ↗

October 02, 2025

Via Benzinga

AI Revolutionizes Professional Services: A New Era for Doctors, Lawyers, and Consultants

October 01, 2025

As of October 1, 2025, Artificial Intelligence (AI) has transcended its nascent stages, becoming an indispensable force in high-value professional tasks across medicine, law, and consulting. This...

Via MarketMinute

Topics Artificial Intelligence

Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration ↗

September 11, 2025

Absci teams up with Oracle and AMD to enhance AI-driven drug discovery using high-performance GPUs.

Via Benzinga

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

September 11, 2025

Performance and scalability of Oracle Cloud Infrastructure AI infrastructure enables Absci to accelerate biologics design cycles and reduce costs

From Absci Corporation; Oracle; AMD

Via GlobeNewswire

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

August 25, 2025

World-renowned experts will guide the clinical development of ABS-201, a therapeutic antibody entering clinical trials for the treatment of androgenetic alopecia.

From Absci Corporation

Via GlobeNewswire

Absci to Participate in Upcoming Investor Conferences

August 20, 2025

From Absci Corporation

Via GlobeNewswire

Absci Sales Fall 54 Percent ↗

August 12, 2025

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

Absci Corp (NASDAQ:ABSI) Q2 2025 Earnings: Revenue Miss Sparks Market Selloff ↗

August 12, 2025

Absci Corp (ABSI) Q2 2025 earnings miss revenue estimates at $0.59M vs. $1.46M, EPS -$0.24. Stock drops 5% post-report despite strong cash position and pipeline progress.

Via Chartmill

Topics Earnings

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

August 12, 2025

From Absci Corporation

Via GlobeNewswire

Earnings Scheduled For August 12, 2025 ↗

August 12, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.